「with the」の検索結果
141件：61～65件目を表示
-
ers: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketing of “Mytear Lumify” (OTC drug requiring instruction by pharmacist, hereinafter this &qu...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
for BeelineMED” in Japan. MIEr for BeelineMED is capable of sharpening indistinct image files taken with various optical devices by installing image sharpening the algorithm developed by Logic and Des...
https://www.senju.co.jp/system/files/content_news/2025-02/ENG_20250220.pdf -
Publications | Research & Development | SENJU Pharmaceutica
d, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutic...
http://www.senju.co.jp/english/rd/thesis/ -
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：...
https://www.senju.co.jp/rd/society/ -
学会发表 | 研究与开发 | 千寿制药株式会社
Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：...
https://www.senju.co.jp/chinese/rd/society/